LYNDHURST, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, today announced that it was again selected to be
part of the Dow Jones Sustainability (DJSI) World and North American Indexes.
The company was first added to the World Index in 2004 and the North American
Index in 2005.
According to DJSI, companies were identified as "sustainability leaders"
and ranked according to objective benchmarks linked to financial,
environmental and social criteria. The DJSI defines corporate sustainability
as "a business approach that creates long-term shareholder value by embracing
opportunities and managing risks deriving from economic, environmental and
social developments. Corporate sustainability leaders achieve long-term
shareholder value by gearing their strategies and management to harness the
market's potential for sustainability products and services while at the same
time successfully reducing and avoiding sustainability costs and risks."
The DJSI Sustainability Indexes are the first global indexes tracking the
financial performance of the leading sustainability-driven companies
worldwide. The indexes provide asset managers with reliable and objective
benchmarks to manage sustainability portfolios. The DJSI World Index contains
approximately 300 companies, and the DJSI North America Index contains
approximately 100 companies that were selected from among the largest 600
North American corporations of the Dow Jones Global Index. DJSI indexes are
produced by Sustainable Asset Management Group (SAM), based in Zurich,
Switzerland, together with Dow Jones Indexes and STOXX Limited. Additional
information about the DJSI, including a list of all component companies, is
available at: www.sustainability-indexes.com.
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its national network of laboratories and patient
service centers, and provides interpretive consultation through its extensive
medical and scientific staff. Quest Diagnostics is a pioneer in developing
innovative new diagnostic tests and advanced healthcare information technology
solutions that help improve patient care. Additional company information is
available at www.questdiagnostics.com.
This communication contains certain forward-looking statements. These
forward-looking statements, which may include, but are not limited to,
statements concerning the proposed acquisition, are based on management's
current expectations and estimates and involve risks and uncertainties that
could cause actual results or outcomes to differ materially from those
contemplated by the forward-looking statements. Certain of these risks and
uncertainties may include, but are not limited to the risks and uncertainties
described in the Quest Diagnostics Incorporated 2006 Form 10-K and subsequent
filings.
SOURCE Quest Diagnostics Incorporated
CONTACT: Investors: Laure Park, +1-201-393-5030, or Media: Wendy Bost,
+1-201-393-5700, both of Quest Diagnostics Incorporated
Web site: http://www.questdiagnostics.com